Latest news with #Epidiolex
Forbes
01-07-2025
- Business
- Forbes
Redeem Therapeutics CBD Review: Products, Testing Standards & More
Redeem Therapeutics is an online cannabidiol ( CBD ) retailer offering CBD gummies , oils , capsules and creams , as well as CBD for pets. Redeem's products are manufactured with USDA-certified organic hemp and are available in various potencies, meaning CBD aficionados may find a high-quality product that suits their unique needs. Based in South Carolina, Redeem Therapeutics launched in 2018. The company notes that transparency and honesty are central to its culture and offers a 60-day money back guarantee to consumers. While the company website also states it offers pharmaceutical-grade products, it's important to highlight that retail CBD is not approved by the U.S. Food and Drug Administration (FDA) to treat any condition. A single pharmaceutical medication containing CBD, Epidiolex, is FDA-approved to treat certain types of seizures. All Redeem Therapeutics CBD products are tested by an independent, third-party laboratory for quality and potency, according to the company. Certificates of analysis (COAs) are available for consumers to view on the company's website. COAs test for potential contaminants, such as pesticides or heavy metals like lead, as well as the potency of CBD, delta-9 tetrahydrocannabinol (THC) and other active hemp plant constituents called terpenes. According to federal regulations, retail CBD products must not contain over 0.3% THC. Are Redeem Therapeutics' Products Lab Tested By Third-Parties? Redeem Therapeutics ensures its CBD products undergo third-party laboratory testing. Each product bottle or label contains a lot number for its unique batch and a QR code, which, when scanned, takes the consumer directly to the company's COA page. Users can then search their product's batch or lot number to verify their purchase meets quality, safety and potency claims Users can also compare results with previous batches to analyze consistency. Cost: Across all of Redeem's product offerings, from CBD gummies to creams, pricing ranges anywhere from $12.99 to $59.99. Across all of Redeem's product offerings, from CBD gummies to creams, pricing ranges anywhere from $12.99 to $59.99. CBD types: Broad-spectrum and full-spectrum CBD products available and full-spectrum CBD products available Quality: Redeem's products are vegan, gluten-free and produced in FDA current good manufacturing practices (cGMP)-compliant facility Redeem Therapeutics achieved 4.7 out of 5 stars on Trustpilot, with over 290 reviews. In fact, 93% of the company's reviews feature five stars. Customer responses are largely positive, with numerous consumers commending the brand's spray and pain products for helping with concerns like chronic back pain and walking more easily without a cane. The brand's Trustpilot page notes that Redeem responds to 100% of its negative reviews, typically replying within 24 hours. Less positive reviews include complaints about products not working properly or offering no effects, as well as glitches with the website or issues with applying discounts. The company replied to numerous consumer complaints about product quality by inviting reviewers to fill out a form on the website to utilize the brand's money-back guarantee. Redeem is not accredited by the Better Business Bureau (BBB), and both reviews and company complaints are unavailable on the brand's BBB page. Redeem Therapeutics: Lab Testing Results Forbes Health facilitated independent, third-party laboratory testing via Nova Analytic Labs for two Redeem Therapeutics products: Extra Strength Optimal Spectrum Hemp Extract and Broad Spectrum Hemp Extract ( product names and brand offerings may have changed from the time of laboratory testing ). Each CBD oil was analyzed for: CBD potency THC potency Potencies of minor cannabinoid types Presence or absence and types of terpenes Detection of pesticides, mycotoxins, microbials and heavy metals Here are our results: Redeem Therapeutics Extra Strength Optimal Spectrum Hemp Extract (tincture) All measurements are per 0.5-milliliter serving. Cannabidiol (CBD): 14.8 milligrams Delta-9-tetrahydrocannabinol (THC): 0.409 milligrams Total cannabinoids: 15.2 milligrams Terpenes: Tested Pesticides: Tested Mycotoxins: Pass Heavy metals: Pass View full third-party laboratory results and the COA here . Redeem Therapeutics Broad Spectrum Hemp Extract All measurements are per the manufacturer-recommended 1-millimeter serving. Cannabidiol (CBD): 56.3 milligrams Delta-9 tetrahydrocannabinol (THC): Not detected Total cannabinoids: 59.7 milligrams Terpenes: Tested Pesticides: Tested Mycotoxins: Pass Heavy metals: Pass View full third-party laboratory results and the COA here . Redeem Therapeutics CBD Potency Redeem Therapeutics sells several gummy, oils, capsule/softgel and cream products in a variety of potencies. Products are available across two of the three types of CBD—full-spectrum and broad-spectrum—and individual product potencies vary, allowing plenty of flexibility to choose products that suit your specific needs and preferences. CBD beginners may prefer to start with low-potency products in Redeem Therapeutic's range, such as their Broad Spectrum CBD Oil (1,500 milligrams of broad-spectrum CBD per container) or CBD Daily Gummies (750 milligrams of broad-spectrum CBD per serving). Broad-spectrum CBD contains only trace amounts of THC, so more experienced users may prefer one of Redeem's full-spectrum CBD products (containing up to 0.3% THC). Since there's no standard dose or potency when it comes to taking CBD, and individual effects vary from person to person and depend on the type of CBD used, experts typically recommend starting with a lower potency. Redeem Therapeutics Price & Quality '[Redeem] craft[s] thoughtful botanical blends to support the body and are available in a range of formats like oils, creams and gummies for convenient, accessible use,' says Lenore Cangeloso , a board-certified acupuncturist and herbal medicine practitioner and Forbes Health Advisory Board member. Its gummy offerings largely range from $39.99 to $43.99 for all bottles; however, there is a 10-count version of the CBD sleep gummies that costs $12.99. Pricing for the brand's oils and sprays is fairly similar, ranging anywhere from $39.99 to $59.99 per bottle. All of Redeem's capsule and softgel offerings are listed as $39.95 per bottle. Its CBD pain cream costs $59.99, while the travel-size version is $29.99. Consider your needs before making your product choice. 'To find the right product, start by identifying your main wellness goal, whether it's better sleep, less stress, or sharper focus,' explains Cangeloso. New users may want to begin with lower-potency formulas, while more experienced users might benefit from products featuring added cannabinoids or higher doses for enhanced effects. When in doubt, consult a healthcare provider for personalized guidance. 'Redeem Therapeutics offers organic, hemp-based CBD products designed for those seeking herbal support for sleep , pain , stress , mood or focus,' says Cangeloso. 'Independent lab testing backs the quality and transparency of each product, confirming CBD and THC levels as well as screening for contaminants like pesticides, heavy metals and microbes, which is very important when researching brands.' Potential downsides could include such risks as interactions with other medications, reproductive or developmental impacts or liver toxicity and drowsiness or sedation among others, per the Substance Abuse and Mental Health Services Administration (SAMHSA). Talk to your doctor before taking CBD to discuss potential downsides, and whether taking CBD is the right choice for you. Pregnant people or those who are breastfeeding should avoid using CBD, as it can contain impurities such as bacteria or pesticides which can carry risks for mothers and babies. Forbes Health covers CBD and cannabis products in accordance with Federal Trade Commission (FTC) guidelines. Learn more about Forbes Health's practices and policies regarding how we cover CBD and cannabis as a publisher.
Yahoo
29-06-2025
- Business
- Yahoo
The 5 Most Interesting Analyst Questions From Jazz Pharmaceuticals's Q1 Earnings Call
Jazz Pharmaceuticals faced a challenging first quarter as revenue remained flat year over year, missing Wall Street expectations. Management attributed the performance to contrasting trends across its portfolio: robust double-digit growth for key neuroscience products, Xywav and Epidiolex, was offset by weaker results in oncology, notably for Zepzelca and Rylaze. CEO Bruce Cozadd described the quarter as one of "meaningful progress" in R&D and commercial execution, but also acknowledged near-term headwinds impacting some oncology products and a significant charge related to legal settlements. The company also noted that operational factors, including an additional inventory burn for Epidiolex and one fewer shipping week in oncology, contributed to the results. Is now the time to buy JAZZ? Find out in our full research report (it's free). Revenue: $897.8 million vs analyst estimates of $986.6 million (flat year on year, 9% miss) Adjusted EPS: $1.68 vs analyst expectations of $4.66 (63.9% miss) Adjusted EBITDA: $206.5 million vs analyst estimates of $399.6 million (23% margin, 48.3% miss) The company reconfirmed its revenue guidance for the full year of $4.28 billion at the midpoint Management lowered its full-year Adjusted EPS guidance to $4.80 at the midpoint, a 79.4% decrease Operating Margin: -6.2%, down from 7.3% in the same quarter last year Market Capitalization: $6.51 billion While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Jason Gerberry (Bank of America) inquired about Jazz's ability to mitigate tariff risks for Xywav supply. CEO Bruce Cozadd confirmed U.S. suppliers can fully meet domestic demand if tariffs are imposed, and there are no major issues sourcing active pharmaceutical ingredients domestically. Jessica Fye (JP Morgan) asked about the broader manufacturing footprint and contingency plans for tariffs. President Renee Gala detailed the mix of U.S. and European facilities, highlighting flexibility and inventory strategies as key mitigation tools. CFO Phil Johnson added that sufficient U.S. inventory has been built to cover 2025 needs. David Amsellem (Piper Sandler) focused on Zepzelca's competitive positioning and future growth as label expansion and new entrants emerge. Gala emphasized ongoing market share strength in second-line therapy and anticipated growth from upcoming first-line approvals and practice-changing data. Annabel Samimy (Stifel) questioned the timeline for Rylaze recovery in adolescent and young adult segments. Gala acknowledged the education challenge but expects normalization in the second quarter and continued long-term growth efforts. Marc Goodman (Leerink Partners) sought clarity on the potential financial impact of tariffs if inventory strategies were exhausted. Johnson refrained from providing hypothetical figures but reiterated current protection from inventory and the ability to source production domestically as needed. In assessing execution over the next several quarters, StockStory analysts will watch for (1) evidence of sustained growth and market share gains for Xywav and Epidiolex as disease awareness initiatives continue, (2) regulatory progress and commercialization for Dordaviprone and zanidatamab, and (3) normalization and renewed momentum for Rylaze and Zepzelca in the oncology portfolio. The impact of potential tariffs and competitive dynamics in both neuroscience and oncology will also be closely monitored. Jazz Pharmaceuticals currently trades at $107.51, down from $111.10 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it's free). Market indices reached historic highs following Donald Trump's presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we're leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Time of India
16-06-2025
- Health
- Time of India
What is CBD oil: Know its health benefits, uses, and scientific backing behind the cannabinoid trend
What is CBD oil: Know its health benefits, uses, and scientific backing behind the cannabinoid trend As CBD oil continues to increase in popularity throughout the wellness, pharmaceutical, and beauty markets, consumers are clamoring to know what exactly this cannabis-derived substance is and how it functions. Cannabidiol (CBD), a non-psychoactive compound that is derived from the Cannabis sativa plant, has risen to global prominence as a result of its described ability to mitigate everything from pain and anxiety disorders to epilepsy and inflammation. Unlike tetrahydrocannabinol (THC), the cannabinoid that causes the "high" in marijuana, CBD has no intoxicating properties. The therapeutic potential of CBD, Medical News Today asserts, is its capacity to work in harmony with the body's natural processes without affecting one's state of mind. The US Food and Drug Administration (FDA) has licensed only one CBD-derived drug (Epidiolex for seizures), yet researchers are now investigating its effectiveness for the treatment of a wide variety of diseases. What is CBD oil and how does it work CBD, or cannabidiol, is one of more than 100 phytochemicals referred to as cannabinoids contained in the cannabis plant. It is mainly derived from hemp, which is a variant of Cannabis sativa containing less than 0.3% THC, guaranteeing non-psychoactive characteristics. According to Healthline, CBD oil is a combination of CBD extract and a carrier oil such as hemp seed oil, MCT oil, or olive oil. It comes in several formats such as tinctures, capsules, edibles, vape liquids, and topical products, each having varying rates of absorption. CBD interacts with the endocannabinoid system (ECS)—a system of receptors (CB1 and CB2), enzymes, and neurotransmitters that assists in controlling essential processes such as mood, sleep, appetite, immune system response, and pain perception. CBD does not bind directly to CB1 or CB2 receptors like THC, but rather boosts the body's natural cannabinoids and also engages with other non-cannabinoid receptors such as serotonin (5-HT1A) and TRPV1 associated with pain and inflammation reactions. Why CBD oil is used CBD oil is commonly used for its medicinal properties and is being adopted by individuals looking for non-addictive, natural products as a substitute for pharmaceutical medications. The following are the most typical reasons why individuals use CBD oil: 1. Pain relief CBD is extensively utilized for the management of chronic pain, such as that due to arthritis, nerve damage, and multiple sclerosis. As per Healthline, CBD's analgesic and anti-inflammatory effects could stem from its action on ECS and pain modulating neurotransmitter systems. 2. Anxiety and depression Research quoted by Medical News Today indicates CBD's effect on the serotonin receptors is likely to control mood, which makes it useful for individuals with generalized anxiety disorder (GAD), PTSD, and depression. It is not a replacement for psychiatric care, but it can be an adjunct treatment. 3. Sleep disorders CBD is utilized in treating insomnia and sleep issues as a result of stress, pain, or anxiety. CBD can enhance sleep without inducing dependency, unlike pharmaceutical sedatives, according to Healthline. 4. Controlling epilepsy and seizures Epidiolex, the first FDA-approved CBD medication, is prescribed for Dravet syndrome and Lennox-Gastaut syndrome, two rare and severe types of childhood epilepsy. The compelling clinical evidence here renders CBD's anticonvulsant effect one of the most studied advantages. 5. Neuroprotection Early lab research indicates CBD can delay the course of neurodegenerative illnesses such as Alzheimer's and Parkinson's. In a 2020 review in Frontiers in Pharmacology, CBD holds hope in minimizing inflammation and oxidative stress but awaits human trials. 6. Skin health CBD is becoming increasingly popular in skin care as an anti-inflammatory and oil-balancing agent. It's now a mainstay in creams and serums employed to manage acne, eczema, and psoriasis. Is CBD the future of medicine? Experts call for more research Although anecdotal accounts remain a driving force in public interest, scientific investigations are still ongoing. As per the Frontiers in Pharmacology 2020 overview, CBD has great therapeutic potential but does not have large-scale clinical trials for the majority of uses. Additional peer-reviewed human studies must validate its safety and efficacy in a broad spectrum of conditions. Is CBD oil legal? Under the 2018 Farm Bill, as quoted in Medical News Today, CBD products from hemp (which contain less than 0.3% THC) became legal at the federal level. There is a wide range of state-level laws, though. Some states permit CBD for use in food and drink or as over-the-counter medicine, whereas others place restrictions, especially around marketing or on THC content. Buyers must always check local legislation before buying or using CBD oil to avoid noncompliance. CBD oil possible side effects and factors CBD is safe overall, but some people might experience: Dry mouth Fatigue or drowsiness Diarrhea Appetite changes or weight changes Interference with medications, including seizure medications and blood thinners Both Healthline and Medical News Today suggest caution for pregnant women or breastfeeding women, and suggest opting for CBD products that have been third-party tested to prevent contaminants like pesticides or heavy metals. One step to a healthier you—join Times Health+ Yoga and feel the change
Fox News
03-06-2025
- General
- Fox News
Cannabis
Cannabis is a drug that comes from the dried leaves, flowers, stems, and seeds of a cannabis sativa plant. Cannabis is commonly referred to as weed or marijuana, though marijuana refers to a specific part of the cannabis plant that contains high amounts of the psychoactive compound THC (tetrahydrocannabinol), which has mind-altering effects. CBD (cannabidiol) is another compound found in cannabis. In a single year, 52.5 million people in the United States use cannabis at least once, according to 2021 data from the Centers for Disease Control and Prevention (CDC). Cannabis has a direct effect on the brain, specifically the parts used for learning, decision-making, emotion, memory, reaction time, coordination, and attention, the CDC states. Marijuana is commonly smoked for recreational purposes. There are few prescription cannabis drugs approved by the Food and Drug Administration (FDA) for medicinal purposes. One example is Epidiolex, which is used to treat seizures. The legalization of marijuana is a varying issue on a state-by-state basis. Some states have legalized marijuana for medicinal purposes, while in others marijuana is legal for both recreational and medicinal purposes. Idaho, Kansas, South Carolina and Wyoming are the only states where marijuana is fully illegal.
Health Line
02-06-2025
- Business
- Health Line
Does Medicare Cover Medical Marijuana (Cannabis)?
Key takeaways Medicare does not cover medical cannabis because it's considered a Schedule I controlled substance federally, and doctors cannot legally prescribe it. Some Part D and Medicare Advantage plans may cover FDA-approved cannabinoid-based medications like cannabidiol (Epidiolex), dronabinol (Marinol, Syndros), and nabilone (Cesamet), but coverage can vary. As of 2023, 39 states and Washington, D.C., have approved the sale and use of medical cannabis, though it remains illegal at the federal level. More states are legalizing medical cannabis with each passing year. That may make you wonder whether Medicare will cover the cost of medical cannabis in your state. Federally, cannabis remains a controlled substance. It's illegal to possess or use the drug under federal law. However, individual states have passed laws allowing distribution and sale within their state boundaries. Medicare won't cover medical cannabis because it's considered a Schedule I controlled substance. In fact, doctors cannot even legally prescribe it. Some people may use medical cannabis to manage symptoms like: pain nausea seizures If you've received a doctor's recommendation and your state has legalized medical cannabis, read on to learn what you need to know about coverage, how and why it's used, and more. Why doesn't Medicare cover medical cannabis? Medicare doesn't cover drugs that are illegal according to the federal government. This includes cannabis for medical use. The Food and Drug Administration (FDA) has not cleared cannabis as a safe and effective treatment for any medical use. That's true even if you live in a state where it's medically legal. This is another reason Medicare won't cover medical cannabis. Learn what Medicare covers. What about Medicare prescription drug plans? Medicare Part C, or Medicare Advantage, is health insurance offered by private insurance companies that provides additional coverage beyond Original Medicare (parts A and B). Extra coverage may include: dental care vision care some prescription drugs Medicare Part D is medical insurance that's also offered through private companies and covers prescription drugs. It doesn't, however, cover medical cannabis. Parts C and D could cover the cost of cannabinoid medications that have been approved by the FDA and are available without restriction. This is where some flexibility exists. Cannabinoid medications may be covered by Medicare drug plans for their intended uses because they're approved by the FDA. These can include: Epidiolex dronabinol (Marinol, Syndros) nabilone (Cesamet) If you're unsure what your plan covers, contact your Medicare prescription drug plan directly. They can help you understand whether you have coverage for any cannabinoid medication and how to fill a prescription. What is medical cannabis used to treat? Some people recommend medical cannabis to ease symptoms like: nausea from chemotherapy loss of appetite inflammation anxiety pain epileptic seizures muscle stiffness Medical cannabis is often suggested to treat the symptoms of stage 3 HIV or cancer. Research suggests it can boost appetite and reduce nausea associated with certain health conditions. If you have multiple sclerosis (MS), medical cannabis may help ease pain and reduce muscle stiffness. Cannabinoid-based medications Dronabinol (Marinol, Syndros) can be used to ease nausea and vomiting from cancer treatment and increase appetite in people with stage 3 HIV. Nabilone (Cesamet) can improve appetite and weight maintenance in people with stage 3 HIV. Epidiolex can help prevent seizures and is used as a treatment for epilepsy. The FDA has approved these medications for these uses. The federal government considers cannabis illegal and holds strict control over it and any cannabinoid-based products. That means research on the possible benefits or even the side effects of cannabis use is limited. Without data from clinical research, the FDA won't be able to update its position on the safety or effectiveness of its medical uses. State medical cannabis laws As of 2023, 39 states and Washington, D.C., have approved the sale and use of medical cannabis. Some of those states have also approved cannabis products for recreational use. In states where only medical cannabis is legal, you're required to get a medical cannabis card. The rules and steps for getting a medical cannabis card may vary from state to state, but here are the basics: Make an appointment with your primary healthcare professional: Your doctor will likely give you a full physical exam and review your medical history. If your doctor thinks medical cannabis might help, they may approve you for a medical cannabis card. Renew your cannabis card annually: This may require follow-up visits. Ask your doctor if there are any other additional steps you'll need to take. Most cannabis cards are registered with the state government. Your doctor can't prescribe cannabis products directly: Federal law prevents doctors from prescribing substances that are illegal. Cannabis remains illegal under federal law. Instead, your doctor may suggest you may benefit from it. Even though all types of cannabis are illegal at the federal level, the federal government hasn't taken steps to prosecute those who use it within a state with legal cannabis trade. However, it's still possible to face prosecution under federal law under certain circumstances. What's the difference between medical cannabis and CBD? Cannabis contains several dozen active chemicals. The two most well known are cannabidiol (CBD) and delta-9-tetrahydrocannabinol, also known as THC. CBD's potential benefits include: improved relaxation pain reduction lowered anxiety THC is the chemical responsible for the psychoactive effects of cannabis. In recent years, CBD has been isolated from THC and is sold even in states that don't allow medical cannabis. In states where medical cannabis is legal, both CBD and THC products are available for a variety of health issues. Like medical cannabis, individual states have their own legislation regarding legal levels of CBD. Check your state's legislation for specific information, and be mindful of other state laws when traveling with CBD. How medical marijuana may affect the opioid crisis Limited research suggests the use of cannabis is reducing the use of opioids and pain medications with high addiction potential. Because cannabis may help relieve some of the same symptoms as opioids, doctors may not prescribe pain medications if cannabis is an option. How do I use medical cannabis? With better processing equipment, medical cannabis producers and distributors have created a variety of cannabis-infused products. Common forms of consumption include: smoking vaping eating (in foods or drinks made with cannabis) spraying under the tongue tinctures topical applications, like oils and creams Talk with your doctor if you're not familiar with how to use medical cannabis or aren't sure which method of consumption might work best for your condition. They can help connect you with resources for understanding proper usage. How much does medical cannabis cost? Medical cannabis cards aren't usually free. Cards generally cost about $50 or more when you first apply. You may also have to pay annual renewal fees. If medical cannabis is approved in your state, check your state government's website for specific cost information. For each renewal, you'll visit your doctor to discuss whether you still need medical cannabis for your condition. This office visit may or may not be covered by your particular Medicare plan. Contact your plan ahead of time to find out if: the visit will be covered there's a copay and, if so, how much it is you'll need to pay the full bill out of pocket In some states, a medical cannabis card gives discounts on cannabis products you purchase. Discounts may cover the cost of the card, depending on the frequency and amount you use. Your Medicare prescription drug plan may cover FDA-approved cannabinoid-based medications like dronabinol (Marinol, Syndros), nabilone (Cesamet), and Epidiolex, at least in part. Prices vary. Check with your doctor for availability and pricing options. You can check your plan's list of covered medications, called a formulary, before filling a prescription or contact your plan directly to ask about coverage. Takeaway Medicare won't cover the cost of medical cannabis because it's federally illegal and not approved by the FDA. However, Medicare may pay for cannabinoid-based medications. You must obtain a medical cannabis card before you can buy cannabis products, even in states where it's available recreationally. A medical cannabis card may provide discounts. If you're curious whether medical cannabis is an option for you, talk with your doctor. Together you can review your symptoms and look for alternatives if your doctor doesn't think cannabis products are the right choice for you. The information on this website may assist you in making personal decisions about insurance, but it is not intended to provide advice regarding the purchase or use of any insurance or insurance products. Healthline Media does not transact the business of insurance in any manner and is not licensed as an insurance company or producer in any U.S. jurisdiction. Healthline Media does not recommend or endorse any third parties that may transact the business of insurance.
